Recombinant vs. plasma-derived products, especially those with intact VWF, regarding inhibitor development.
| Autor: | ETTINGSHAUSEN, C. ESCURIOLA1 carmen.escuriola@kgu.d, KREUZ, W.1 |
|---|---|
| Zdroj: | Haemophilia. Dec2006 Supplement 3, Vol. 12, p102-106. 5p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|